Morgan Stanley’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,378
Closed -$72K 7243
2020
Q3
$72K Sell
1,378
-1,472
-52% -$76.9K ﹤0.01% 5576
2020
Q2
$174K Sell
2,850
-2,920
-51% -$178K ﹤0.01% 5139
2020
Q1
$326K Sell
5,770
-2,598
-31% -$147K ﹤0.01% 4617
2019
Q4
$477K Buy
8,368
+6,055
+262% +$345K ﹤0.01% 4953
2019
Q3
$123K Buy
2,313
+1,638
+243% +$87.1K ﹤0.01% 5365
2019
Q2
$40K Sell
675
-15,656
-96% -$928K ﹤0.01% 5705
2019
Q1
$1.02M Buy
16,331
+6,358
+64% +$396K ﹤0.01% 4101
2018
Q4
$605K Sell
9,973
-18,914
-65% -$1.15M ﹤0.01% 4662
2018
Q3
$1.69M Buy
28,887
+4,423
+18% +$259K ﹤0.01% 4144
2018
Q2
$1.1M Sell
24,464
-2,291
-9% -$103K ﹤0.01% 4568
2018
Q1
$1.19M Sell
26,755
-1,806
-6% -$80.1K ﹤0.01% 4424
2017
Q4
$1.24M Buy
28,561
+7,571
+36% +$328K ﹤0.01% 4401
2017
Q3
$977K Sell
20,990
-1,099
-5% -$51.2K ﹤0.01% 4446
2017
Q2
$1.09M Buy
22,089
+11,246
+104% +$556K ﹤0.01% 4308
2017
Q1
$594K Sell
10,843
-7,748
-42% -$424K ﹤0.01% 4734
2016
Q4
$1.04M Buy
18,591
+16,403
+750% +$913K ﹤0.01% 4436
2016
Q3
$101K Buy
2,188
+1,985
+978% +$91.6K ﹤0.01% 5309
2016
Q2
$8K Sell
203
-5,655
-97% -$223K ﹤0.01% 6119
2016
Q1
$204K Sell
5,858
-2,865
-33% -$99.8K ﹤0.01% 4965
2015
Q4
$374K Sell
8,723
-35,552
-80% -$1.52M ﹤0.01% 4736
2015
Q3
$1.93M Buy
44,275
+5,393
+14% +$235K ﹤0.01% 3549
2015
Q2
$2.01M Buy
38,882
+2,785
+8% +$144K ﹤0.01% 3623
2015
Q1
$1.41M Sell
36,097
-37,497
-51% -$1.47M ﹤0.01% 3870
2014
Q4
$2.84M Buy
73,594
+13,388
+22% +$517K ﹤0.01% 3249
2014
Q3
$2.13M Buy
60,206
+19,720
+49% +$696K ﹤0.01% 3387
2014
Q2
$1.09M Buy
40,486
+33,259
+460% +$896K ﹤0.01% 3985
2014
Q1
$187K Buy
7,227
+727
+11% +$18.8K ﹤0.01% 5150
2013
Q4
$141K Sell
6,500
-6,172
-49% -$134K ﹤0.01% 5202
2013
Q3
$247K Sell
12,672
-3,702
-23% -$72.2K ﹤0.01% 4758
2013
Q2
$255K Buy
+16,374
New +$255K ﹤0.01% 4697